CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 6928 result(s)

Clinical and economic considerations in the use of fluoroquinolones

Last Updated: January 1, 1997
Result type: Reports

Cite as: Glennie JL. Clinical and economic considerations in the use of fluoroquinolones. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Fluoroquinolones (also generally referred to as "quinolones") are a class of antimicrobial drugs which, as a group, have a broad spectrum of activity against ...

The Use of G-CSF in the Prevention of Febrile Neutropenia

Last Updated: January 1, 1997
Result type: Reports

Cite as: Perras C, Otten N. The Use of G-CSF in the Prevention of febrile neutropenia. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Febrile neutropenia is a life-threatening complication of cancer drugs. Granulocyte colony-stimulating factor (G-CSF), reproduced by recombinant DNA technology, ...

An Economic Analysis of Sumatriptan for Acute Migraine

Last Updated: January 1, 1997
Result type: Reports

Cite as: Ilersich L. An economic analysis of sumatriptan for acute migraine. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Migraine is an episodic headache that may be either a steady or throbbing pain. Episodes of migraine can vary in intensity, frequency and duration, and are often accompani...

Assessment of Techniques for Cervical Cancer Screening

Last Updated: January 1, 1997
Result type: Reports

Cite as: Noorani HZ. Assessment of techniques for cervical cancer screening. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Cervical cancer is one of the few readily preventable forms of cancer. Although the Papanicolaou (Pap) smear has had an enormous impact on the incidence and mortality rates of cervica...

Pulmozyme: Clinical and Economic Impacts

Last Updated: January 1, 1996
Result type: Reports

Cite as: Perras C, Otten N. Pulmozyme: clinical and economic impacts. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Summary Remarks This overview is based on data obtained in a study commissioned by CCOHTA entitled "A Pharmacoeconomic Evaluation of DNase Use in Cystic Fibrosis" and the Phase III clinical...

Use of Nitrates in Chronic Stable Angina

Last Updated: January 1, 1996
Result type: Reports

Cite as: Perras C. The use of nitrates in chronic stable angina. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Nitrates are one of many agents indicated in the management of angina. For many years, isosorbide dinitrate (ISDN) was widely prescribed in the prevention and treatment of anginal attacks, but it...

Finasteride: Clinical and Economic Impacts

Last Updated: January 1, 1996
Result type: Reports

Cite as: Otten N. Finasteride: clinical and economic impacts. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Introduction Benign prostatic hypertrophy (BPH) is the most common benign neoplasm in males. Even though microscopic evidence of BPH is evident in approximately 50% of men aged 60 and over, only 25...